Aspire Biopharma Holdings, Inc. - Common Stock (NQ:ASBP)

0.7099 -0.1655 (-18.91%)

Streaming Delayed Price Updated: 2:12 PM EDT, Mar 18, 2026 Add to My Watchlist

Price and Volume

Volume	251,816
Open	0.8491
Bid (Size)	0.6857 (100)
Ask (Size)	0.7100 (1,000)
Prev. Close	0.8754
Today's Range	0.6701 - 0.8987
52wk Range	0.7600 - 35.01
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director

March 17, 2026

Via ACCESS Newswire

Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026

March 12, 2026

Via ACCESS Newswire

Performance

YTD	-87.0%	-87.0%
1 Month	-55.4%	-55.4%
3 Month	-83.0%	-83.0%
6 Month	-96.0%	-96.0%
1 Year	-97.2%	-97.2%

More News

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack

March 10, 2026

Via ACCESS Newswire

Stay updated with the stocks that are on the move in today's after-hours session. ↗

March 06, 2026

Via Chartmill

Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief

March 03, 2026

Via ACCESS Newswire

Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship

February 25, 2026

Via ACCESS Newswire

Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements

February 20, 2026

Via ACCESS Newswire

Aspire Biopharma's Buzz Bomb Caffeine Company Names ChicExecs as Public Relations Agency of Record

February 19, 2026

Via ACCESS Newswire

Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))

February 17, 2026

Via ACCESS Newswire

Aspire Biopharma Announces the Appointment of New Member to Its Board of Directors

February 13, 2026

Via ACCESS Newswire

Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Ondansetron (Generic Zofran(R))

February 12, 2026

Via ACCESS Newswire

Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq Requirements

February 11, 2026

Via ACCESS Newswire

Aspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

February 10, 2026

Via ACCESS Newswire

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit

February 05, 2026

Via ACCESS Newswire

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution

February 03, 2026

Via ACCESS Newswire

Let's take a look at the stocks that are in motion in today's session. ↗

January 30, 2026

Via Chartmill

Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity

January 22, 2026

Via ACCESS Newswire

Aspire Biopharma's Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign

January 21, 2026

Via ACCESS Newswire

Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam - Generic Xanax(R) - for Rapid Anxiety Relief

January 20, 2026

Via ACCESS Newswire

Which stocks are moving on Thursday? ↗

January 15, 2026

Via Chartmill

Top stock movements in today's session. ↗

January 14, 2026

Via Chartmill

Top movers analysis in the middle of the day on 2026-01-14: top gainers and losers in today's session. ↗

January 14, 2026

Via Chartmill

Traders are paying attention to the gapping stocks in Wednesday's session. ↗

January 14, 2026

Via Chartmill

Aspire Biopharma Announces Reverse Stock Split

January 14, 2026

Via ACCESS Newswire

Most active stocks in Thursday's session ↗

January 08, 2026

Via Chartmill

Frequently Asked Questions

Is Aspire Biopharma Holdings, Inc. - Common Stock publicly traded?

Yes, Aspire Biopharma Holdings, Inc. - Common Stock is publicly traded.

What exchange does Aspire Biopharma Holdings, Inc. - Common Stock trade on?

Aspire Biopharma Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Aspire Biopharma Holdings, Inc. - Common Stock?

The ticker symbol for Aspire Biopharma Holdings, Inc. - Common Stock is ASBP on the Nasdaq Stock Market

What is the current price of Aspire Biopharma Holdings, Inc. - Common Stock?

The current price of Aspire Biopharma Holdings, Inc. - Common Stock is 0.7099

When was Aspire Biopharma Holdings, Inc. - Common Stock last traded?

The last trade of Aspire Biopharma Holdings, Inc. - Common Stock was at 03/18/26 02:12 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.